Syntarga B.V.

Syntarga is active in site-specific (targeted) drug delivery. We offer releasable linker technologies for efficient drug targeting. Linker length and drug loading ratios can be varied, with the goal of enhancing drug release. The company has used its proprietary technology to create effective new anticancer medicines. We aim to out-license our technology and or preclinical products.

Activity:

- Contract Research
- Licensing & Business Development
- Research & Development

Product / Technology type(s) covered:

- Drug delivery
- Enzymes
- Pharmaceuticals / Therapeutics
- Prescription drugs (Rx)
- Technology

Therapeutic targets:

- Cancer
- Oncology

Markets Covered

a. HeadQuarter: Netherlands

b. Continent(s) active: North America , Europe , Asia , Australia/New-Zealand , Central/South America

c. Countries active:

Corporate data:

Number of Employees: -

Turnover:

Amount:	Year:	Currency:
-	2002	Euro

Year founded: 2002